Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.80, $0.28 better than the analyst estimate of $1.52. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $10.68 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2025 EPS of $6.70-$7.00, versus the consensus of $6.74. Bristol-Myers Squibb sees FY2025 revenue of $45.8-46.8 billion, versus the consensus of $45.76 billion.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.